These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2844740)

  • 1. Properties of light and heavy vesicles simultaneously prepared from hog gastric mucosae.
    Asano S; Iino T; Tabuchi Y; Takeguchi N
    J Biochem; 1988 Apr; 103(4):672-7. PubMed ID: 2844740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of carbachol or histamine stimulation on rat gastric membranes enriched in (H+-K+)-ATPase.
    Im WB; Blakeman DP; Fieldhouse JM; Rabon EC
    Biochim Biophys Acta; 1984 May; 772(2):167-75. PubMed ID: 6326823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cl- channel in hog gastric vesicles is part of the function of H,K-ATPase.
    Asano S; Inoie M; Takeguchi N
    J Biol Chem; 1987 Sep; 262(27):13263-8. PubMed ID: 2443490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of rat gastric heavy and light microsomal membranes enriched in (H+-K+)-ATPase using 2H2O and Percoll gradients.
    Im WB; Davis JP; Blakeman DP
    Biochem Biophys Res Commun; 1985 Sep; 131(2):905-11. PubMed ID: 2996531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of (H+ + K+)-ATPase by omeprazole in isolated gastric vesicles requires proton transport.
    Lorentzon P; Jackson R; Wallmark B; Sachs G
    Biochim Biophys Acta; 1987 Feb; 897(1):41-51. PubMed ID: 3026477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase.
    Keeling DJ; Malcolm RC; Laing SM; Ife RJ; Leach CA
    Biochem Pharmacol; 1991 Jun; 42(1):123-30. PubMed ID: 1648919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The specificity of omeprazole as an (H+ + K+)-ATPase inhibitor depends upon the means of its activation.
    Keeling DJ; Fallowfield C; Underwood AH
    Biochem Pharmacol; 1987 Feb; 36(3):339-44. PubMed ID: 3028428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole, a specific inhibitor of gastric (H+-K+)-ATPase, is a H+-activated oxidizing agent of sulfhydryl groups.
    Im WB; Sih JC; Blakeman DP; McGrath JP
    J Biol Chem; 1985 Apr; 260(8):4591-7. PubMed ID: 2985559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric H+-K+-ATPase in situ: relation to secretory state.
    Hersey SJ; Steiner L; Matheravidathu S; Sachs G
    Am J Physiol; 1988 Jun; 254(6 Pt 1):G856-63. PubMed ID: 2837098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of (H+ + K+)-ATPase and H+ accumulation in hog gastric membranes by trifluoperazine, verapamil and 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate.
    Im WB; Blakeman DP; Mendlein J; Sachs G
    Biochim Biophys Acta; 1984 Feb; 770(1):65-72. PubMed ID: 6320882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium-stimulated ATPase activity and hydrogen transport in gastric microsomal vesicles.
    Lee HC; Breitbart H; Berman M; Forte JG
    Biochim Biophys Acta; 1979 May; 553(1):107-31. PubMed ID: 36910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actions of antisecretory agents on proton transport in hog gastric microsomes.
    Nagaya H; Satoh H; Maki Y
    Biochem Pharmacol; 1987 Feb; 36(4):513-9. PubMed ID: 3030328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of action of the gastric microsomal (H+ + K+)-ATPase inhibitors SCH 32651 and SCH 28080.
    Scott CK; Sundell E; Castrovilly L
    Biochem Pharmacol; 1987 Jan; 36(1):97-104. PubMed ID: 3026407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole, SCH 28080 and doxepin differ in their characteristics to inhibit H+/K+-ATPase driven proton accumulation by parietal cell membrane vesicles.
    Beil W; Staar U; Schünemann P; Sewing KF
    Biochem Pharmacol; 1988 Dec; 37(23):4487-93. PubMed ID: 2849447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCH 28080 is a lumenally acting, K+-site inhibitor of the gastric (H+ + K+)-ATPase.
    Keeling DJ; Laing SM; Senn-Bilfinger J
    Biochem Pharmacol; 1988 Jun; 37(11):2231-6. PubMed ID: 2837231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopurification of gastric parietal cell tubulovesicles.
    Bayle D; Benkouka F; Robert JC; Peranzi G; Soumarmon A
    Comp Biochem Physiol B; 1992 Apr; 101(4):519-25. PubMed ID: 1319305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody which inhibits H+/K(+)-ATPase activity but not chloride conductance.
    Benkouka F; Péranzi G; Robert JC; Lewin MJ; Soumarmon A
    Biochim Biophys Acta; 1989 Dec; 987(2):205-11. PubMed ID: 2557927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finding of a KCl-independent, electrogenic, and ATP-driven H+-pumping activity in rat light gastric membranes and its effect on the membrane K+ transport activity.
    Im WB; Blakeman DP; Davis JP
    J Biol Chem; 1986 Sep; 261(25):11686-92. PubMed ID: 2875068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indomethacin inhibition of hog gastric H+/K(+)-ATPase arises from its effect on both the enzyme protein and the lipid bilayer.
    Du J; Li SG; Lin ZH
    J Biochem; 1994 Aug; 116(2):250-6. PubMed ID: 7822239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ion transport studies with H+-K+-ATPase-rich vesicles: implications for HCl secretion and parietal cell physiology.
    Wolosin JM
    Am J Physiol; 1985 Jun; 248(6 Pt 1):G595-607. PubMed ID: 2408481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.